ReviewPharmaceuticals (Basel, Switzerland)2024

Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical Review.

Nikolaos Velidakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.